Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.660
-0.040 (-2.35%)
May 28, 2026, 12:31 PM EST
Cannara Biotech Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cannara Biotech stock has a consensus rating of "Strong Buy" and an average price target of $3.19. The average 1-year stock price forecast is 92.17% higher than the current stock price, while the lowest is $3.00 (+80.72%) and the highest is $3.50 (+110.84%).
Price Target: $3.19 (+92.17%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cannara Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Atrium Research | Atrium Research | Buy Maintains $3.00 | Buy | Maintains | $3.00 | +80.72% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $3.25 | Buy | Maintains | $3.25 | +95.78% | Apr 16, 2026 |
| Haywood | Haywood | Buy Initiates $3.00 | Buy | Initiates | $3.00 | +80.72% | Apr 7, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.